fda compounding semaglutide crackdown 2025 news National Hispanic Medical Association | After compounded GLP-1 drugs were banned, counterfeit versions continued to circulate — and still do today. Understanding the risks and The FDA's Decision to Ban
Description
doi: 10.3748/wjg.v21.i40.11353 57 MarsR
~ AlphaMD Look, I get it
An FDA database analysis shows that reported adverse skin events after GLP-1 receptor agonist use are rare but can include rash and pruritus, highlighting a need for further research, according to a study
It creates a shock to the body and shifts hairs into a resting phase, says Santa Monica-based board-certified dermatologist Karyn Grossman, MD
Back Ferguson, D (20 April 2025) 'The end of WeightWatchers
The moment you do this, you've started a ticking clock
